317 participants
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2024-05-24
- Completion:
- 2026-05-14
Conditions
- Asthma
Interventions
- DRUG
No Results Yet